The quest for novel chemical matter and the contribution of computer-aided de novo design.
Identifying novel chemical matter is the focus of many drug discovery efforts. Through these efforts, computer-based de novo design of drug-like molecules, which aim to build an entire molecule 'from scratch', has emerged as a valuable approach to identify novel chemical matter. In this paper, the author discusses the recent research efforts that aim to build, in silico, more chemically accessible molecules, sample more efficiently the chemical space and rank the proposed molecules. The author reviews de novo design algorithms developed between 2008 and 2010 and the issue of validation, and highlights some recent successful applications of de novo design to drug discovery projects. Although research has addressed the lack of synthetic accessibility of the molecules proposed by the first generation of de novo design tools, the lack of accurate scoring function remains a major limitation of structure-based de novo design. However, de novo design is a valuable approach to generate either chemical starting points or ideas.
Novartis Institute for BioMedical Research, Global Discovery Chemistry, Computer-Aided Drug Discovery, Forum 1, CH-4002 Basel, Switzerland  +41 61 32 45 620 ;  bernard.pirard@novartis.com.
Bernard
B
Pirard